Actavis, Warner Chilcott
Actavis, Inc. will have to sell the rights and assets to three oral contraceptives and an osteoporosis treatment in exchange for the right to buy Warner Chilcott for $8.5 billion, under...To view the full article, register now.
Already a subscriber? Click here to view full article